Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 29, 2015 2:08 AM ET


Company Overview of APT Pharmaceuticals, Inc.

Company Overview

APT Pharmaceuticals, Inc. engages in the development of cyclosporine inhalation solution for the prevention of chronic rejection in lung transplantation. Its cyclosporine inhalation solution is an inhaled formulation of cyclosporine A, an oral medication is used to prevent rejection in solid organ transplant recipients. The company was founded in 1999 and is based in Burlingame, California.

700 Airport Boulevard

Suite 350

Burlingame, CA 94010

United States

Founded in 1999





Key Executives for APT Pharmaceuticals, Inc.

Chief Operating Officer
Chief Commercial Officer and Head of Commercial & Business Development
Global Head of Regulatory Affairs and Executive Vice President of Development - Europe
Vice President of Finance and Strategic Planning
Chief Technology Officer
Age: 54
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Bachem, Inc. United States
Miza Pharmaceuticals USA United States
Midway Pharmaceuticals Inc. United States
CBA Pharma, Inc. United States
PharmPro Services United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact APT Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at